NASDAQ: RPRX
Royalty Pharma PLC Stock Ownership - Who owns Royalty Pharma?

Insider buying vs selling

Have Royalty Pharma PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Marshall UristEVP Research Investments2025-12-0523,334$39.15
$913.60kSell
Marshall UristEVP Research Investments2025-12-0518,242$39.15
$714.23kSell
George W. LloydEVP Investments CLO2025-12-03110,000$39.77
$4.38MSell
Terrance P. CoyneEVP CFO2025-12-013,750$39.87
$149.50kSell
Terrance P. CoyneEVP CFO2025-12-0165,832$39.87
$2.62MSell
Marshall UristEVP Research Investments2025-12-0118,242$39.90
$727.86kSell
Marshall UristEVP Research Investments2025-12-0123,333$39.93
$931.64kSell
Terrance P. CoyneEVP CFO2025-11-2410,686$37.96
$405.64kSell
Terrance P. CoyneEVP CFO2025-11-243,126$38.67
$120.88kSell
Terrance P. CoyneEVP CFO2025-11-24624$37.96
$23.69kSell

1 of 3

RPRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RPRX insiders and whales buy or sell their stock.

RPRX Shareholders

What type of owners hold Royalty Pharma PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Morgan Stanley7.65%44,163,954$1.70BInstitution
Adage Capital Partners GP LLC6.71%38,714,280$1.49BInsider
Fmr LLC4.85%27,986,714$1.07BInstitution
Capital International Investors4.71%27,212,694$1.04BInstitution
Blackrock Inc4.54%26,200,503$1.01BInstitution
1978 Sicaf Sif Sa 1. Gg3.83%22,081,156$847.70MInsider
1978 Sicaf Sif Sa Gg3.71%21,426,170$822.55MInsider
Baillie Gifford Co3.01%17,372,502$666.93MInstitution
Swedbank Ab2.11%12,200,270$468.37MInstitution
Adage Capital Partners GP LLC2.07%11,965,633$459.36MInstitution

1 of 3

RPRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RPRX56.76%17.37%Net SellingNet Selling
BNTX20.98%0.00%
UTHR86.70%13.30%Net SellingNet Selling
GMAB96.17%0.00%
INCY77.68%22.32%Net SellingNet Selling

Royalty Pharma Stock Ownership FAQ

Who owns Royalty Pharma?

Royalty Pharma (NASDAQ: RPRX) is owned by 56.76% institutional shareholders, 17.37% Royalty Pharma insiders, and 25.87% retail investors. Adage Capital Partners GP LLC is the largest individual Royalty Pharma shareholder, owning 38.71M shares representing 6.71% of the company. Adage Capital Partners GP LLC's Royalty Pharma shares are currently valued at $1.49B.

If you're new to stock investing, here's how to buy Royalty Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.